Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ Th1-like responses

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 1010-1020

  Berg, Daniel J ^a   Davidson, Natalle ^a   Kühn, Ralf ^b   Müller, Werner ^b   Menon, Satish ^a   Holland, Gina ^a   Thompson Snipes, Luann ^a   Leach, Michael W ^a   Rennick, Donna ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

adenocarcinoma; genetic susceptibility; IL 10 therapy; inflammatory bowel disease, colitis, IFN

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON CANCER; CONTROLLED STUDY; DISEASE COURSE; ENTEROCOLITIS; GENE DISRUPTION; IMMUNE RESPONSE; INFECTION SENSITIVITY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0029813545     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118861     Document Type: Article

References (47)

1. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
2. Moore, K.W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
3. de Waal-Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulalory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
4. Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
5. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
6. Berg, D.J., R. Kühn, K. Rajewsky, W. Müller, S. Menon, N. Davidson, G. Grünig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96:2339-2347.
7. Berg, D.J., M.W. Leach, R. Kühn, K. Rajewsky, W. Müller, N.J. Davidson, and D. Rennick. 1995. Interleukin-10 hut not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99-108.
8. Mombaerts, P., E. Mizoguhi, M.J. Grusby, L.H. Glimcher, A.K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:274-282.
9. i2-deficient mice. Nat. Genetics 10:143-149.
10. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawloski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature (Lond.). 359:693-699.
11. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
12. Holländer, G.A., S.J. Simpson, E. Mizoguchi, A. Nichogiannopoulou, J. She, J-C. Gutierrez-Ramos, A.K. Bhan, S.J. Burakoff, B. Wang, and C. Terhorst. 1995. Severe colitis in mice with aberrant thymic selection. Immunity. 3:27-38.
13. + T cells. Immunity. 1:553-562.
14. + T cells. J. Exp. Med 178:237-244.
15. Lewin, K.J., Riddell, R.H., and W.M. Weinstein. 1992. Inflammatory Bowel Disease. Gastrointestinal Pathology and Its Clinical Implications. Igaku-Shoin. New York. 812-989.
16. Podolsky, D.K. 1991. Inflammatory bowel disease I. N. Engl. J. Med. 325:928-937.
17. Lowes, J.R., and D.P. Jewell 1990. The immunology of inflammatory bowel disease. Springer Sem. Immunopathol. 12:251-268.
18. Sartor, R.B. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. 1994. Gastroenterol. 106:533-539.
19. MacDonald, T.T. and J. Spencer. 1988. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med 167:1341-1349.
20. Podolsky, D.K. 1991. Inflammatory bowel disease II. N. Engl. J. Med. 325:1008-1016.
21. Sartor, R.B. 1992. Role of the intestinal microflora in pathogenesis and complications. In Inflammatory Bowel Diseases: Pathophysiology as Basis of Treatment. J. Scholmerich, H. Goebell, W. Druis, and W. Hohenberger, editors. Kluwer Academic Publishers, London. 175-187.
22. Ho, A., Y. Liu, T.A. Khan, D. Hsu, J.F. Bazan, and K.W. Moore. 1993. A receptor for interleukin-10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA 90:11267-11271.
23. Lefrançois, L. 1993. Isolation of mouse small intestine intraepithelial lymphocytes. In Current Protocols in Immunology. Vol. 1. J.E. Coligan, A.M. Kruisbeek, O.H. Margulies, E.M. Shevach and W. Strober, editors. John Wiley and Sons, Inc., New York, 3.19.1-3.19.7.
24. Boudard, F., N. Vallot, C. Cabaner, and M. Bastide. 1994. Chemiluminescence and nitrite determinations by the MALU macrophage cell line. J. Immunol. Meth. 174:259-268.
25. + T cells. J. Immunol. 144:3288-3295.
26. Schaedler, R.W., R. Dubos, and R. Costello. 1965. The development of the bacterial flora in the gastrointestinal tract of mice. J. Exp. Med. 122:59-66.
27. Brynjolfsson, G., and L.S. Lombard. 1993. Colitis cystica in mice. Cancer. 23:225-229.
28. Boothe, A.D., and N.F. Cheville. 1967. The pathology of proliferative ileitis of the golden Syrian hamster. Path. Vet. 4:31-44.
29. Epstein, S.E., W.Q. Ascari, R.C. Ablow, W. Seaman, and R. Lattes. 1966. Colitis cystica profunda. Am. J. Clin. Path. 45:186-201.
30. Wayte, D.M., and E.B. Helwig. 1967. Colitis cystica profunda. Am. J. Clin. Path. 48:159-169.
31. Rowlatt, C., and F.C. Chesterman. 1979. Tumours of the intestines and peritoneum. In Pathology of Tumours in Laboratory Animals. V.S. Turusov, editor. International Agency for Research on Cancer, Lyon. 169-191.
32. Korelitz, B.I. 1990. Considerations of surveillance, dysplasia, carcinoma of the colon in the management of ulcerative colitis and Crohn's disease. Med. Clin. North. Am. 74:189-199.
33. Petras, R.E., J.H. Mir-Madjlessi, and R.G. Farmer. 1987. Crohn's disease and intestinal carcinoma. A report of II cases with emphasis on associated dysplasia. Gastroenterol. 93:1307-1314.
34. Orholm, M., P. Mukholm, E. Langholz, O.H. Nielsen, T.I.A. Sorensen, and V. Binder. 1991. Familial occurrence of inflammatory bowel disease. N. Engl. J. Med. 324:84-88.
35. Yang, H., T. Shohat, and J.I. Rotter. 1992. The genetics of inflammatory bowel disease. In Current Topics of Gastroenterology. R.P. MacDermott, W.F. Stenson, editors. Elsevier. pp. 17-51.
36. Sundberg, J.P., C.O. Elson, H. Bedigian, and E.H. Birkenmeier. 1994. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterol. 107:1726-1735.
37. Cherwinski, J.M., J.H. Schumacher, K.D. Brown, and T.R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
38. Colgan, S.P., C.A. Parkos, C. Delp, M.A. Arnaout, and J.L. Madara. 1993. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN gamma in a highly polarized fashion. J. Cell Biol. 120:785-798.
39. Madara, J.L., and J. Stafford. 1989. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83: 724-727.
40. Beagley, K.W., and C.O. Elson. 1992. Cells and cytokines in mucosal immunity and inflammation. Gastroenterol. Clin. North. Am. 21:347-366.
41. Trinchieri, G., and B. Perrussia. 1985. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today. 6:131-136.
42. Ligumsky, M., P.L. Simon, F. Karmeil, and D. Rachmilewitz. 1990. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut. 31:686-689.
43. Mahida, Y.R., K. Wu, and D. Jewell. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut. 30:835-838.
44. MacDonald, T.T., P. Hutchings, M.Y. Choy, S. Murch, and A. Cooke. 1990. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin. Exp. Immunol. 81:301-305.
45. Reinecker, H.-C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumor necrosis factor-alpha, IL-6, IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94:174-181.
46. Cominelli, F., C.C. Nast, and B.D. Clark. 1990. Interleukin 1 (IL-1) gene expression, synthesis and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86:927-980.
47. Schreiber, S., T. Heinig, H.-G. Thiele, and A. Raedler. 1995. Immunoregulatory role of interleukin 10 in inflammatory bowel disease in vitro and in vivo. Gastroenterol. 108:1434-1444.